Molecular Docking and Pharmacokinetic Prediction of Potential Compounds from Luffa acutangula as Antidiabetic Candidates
DOI:
https://doi.org/10.30595/pharmacy.v0i0.16066Keywords:
Antidiabetic, Docking molecular, Luffa acutangula, Pharmacokinetic predictionAbstract
Luffa acutangula is commonly used, but its considerable potential as an alternative treatment for diabetics with a molecular target action is not yet known. Preliminary study of bioinformatics to decipher the compounds of L. acutangulaable to interact with the protein targets of antidiabetic therapy. This study aims to identify the potential compounds of L. acutangula that are thought to interact with the insulin receptor, aldose reductase, and PTP-1B, as well as provide predictions of pharmacokinetics and toxicity. Molecular docking was conducted in AutoDock 4.2.6 with the stages initiated by the preparation of macromolecules (PDB ID: 1IR3; 2PEV; 4Y14) and ligands, molecular docking, and visualization. The pharmacokinetic profiles are predictable by using the Swiss ADME and toxicity estimates by Toxtree. The results showed that cucurbitacin B, cucurbitacin E, oleanolic acid, catechin, ferulic acid and apigenin are the most potential compounds to interact with the macromolecular with a binding energy response similar to the native ligand. Pharmacokinetic predictions show that cucurbitacin B and cucurbitacin E deviate from one Lipinski rule (BM> 500), do not diffuse into the blood brain barrier, are not CYP450 inhibitors, as well as classified as Pgp substrates. The prediction of toxicity indicates that all potential compounds are classified as high toxicity compounds with a risk of narcosis, except oleanolic acid and ferulic acid. These compounds are not genotoxic or non-genotoxic carcinogens.
References
Banu GS. (2017). Cucurbitacin augments insulin sensitivity and glucose uptake through translocation and activation of GLUT4 in PI3K/Akt signaling. World journal of pharmaceutical 6(8): 1078-1096.
Causido-siah A, Petrova T, Hazemann I, Mitschler A, Ruiz FX. (2012). Crystal packing modifies ligand binding affinity: The case of aldose reductase. Wiley Periodical Inc.
Chandramohan, K., Valli, R., Mageswari, B. (2017). Synthesis and characterization of zinc nanopartical from Luffa acutangula. International journal of scientific research: Vol. 6(2): 338-340.
Cheng K, Liu J, Sun H, Xie J. (2010). Synthesis of oleanolic acid dimers as inhibitors ogf glycogen phosphorylase. Chemistry and biodiversity 7: 690-697.
Dakeng S, Duangmano S, Jiratchariyakul W, Pratya YU, Bogletr O. (2012). Inhibition of Wnt signaling by Cucurbitacin B in breast cancer cells: reduction of Wnt-Associated protein and reduced translocation of galectin-3-mediated catenin. Journal of cellular biochemistry 113: 49-60.
Fadel, M. (2019). Uji aktivitas antidiabetes dan identifikasi senyawa biji oyong (Luffa acutangula (L.) Roxb). Surakarta: Universitas Setia Budi.
Fiori GML, D’Agate S, Rocha A, Pereira AM, Pasqua OD. (2017). Development and validation of quantification method for cucurbitacins E and I in rat plasma: Application to population pharmacokinetic study. Journal of pharmaceutical and biomedical analysis.
Forli S, Huey R, Pique ME, Sanner M. (2016). Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols. 11 (5): 905-919.
Greenfield JR, Chisholm DJ. (2004). Thiazolidinediones – mechanisms of action. Journal of experimental and clinical pharmacology. 27 (3): 67-70.
Gry J, Soborg I, Anderson HC. (2006). Cucurbitacins in plant food. Copenhagen: Nordiac council of ministers.
Hsing HY, Rathnasamy S, Dianita R, Wahab HA. (2020). Docking based virtual screening in search of natural PTP1B inhibitors in treating type-2 diabetes mellitus and obesity. Biomedical research and therapy 7(1): 3579-3592.
Hubbard SR. (1997). Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. The EMBO Journal 16 (18): 5573-5581.
Hunsakunachai N, Nuengchamnong N, Jiratchariyakul W, Kummalue T, Khemawoot P. (2019). Pharmacokinetics of cucurbitacin B from Trichosanthes cucumerina in rats. BMC Complementary and alternative medicine 19: 157.
Ideaconsult. (2011). Toxtree User Manual 5th Version. Sofia, Bulgaria.
Kim KH, Lee IS, Park JY, Jang HJ. (2018). Cucurbitacin B Induces Hypoglicemic Effect in Diabetic Mice by Regulation of AMP-Activated Protein Kinase and GLP-1. Front Pharmacol 9(071).
Lipinski CA, Lombardo F, Segawa T, Ko D. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting. Adv. Drug Deliv Rev. 46: 3-26.
Marrewijck LM, Steven W, Marcel PH, Kuruvilla D, Chang MR, Shin Y, Theodore M. (2015). SR2067 Reveals a Unique Kinetic and Structural Signature for PPARγ Partial Agonism. ACS Chem. Biol 11: 273-283.
Ministry of Health RI. (2018). Riset Kesehatan Dasar 2018. Kementerian Kesehatan RI: Badan Penelitian dan Pengembangan Kesehatan.
Murtaza M, Khan G, Aftab MH, Afridi SK, Ghaffar S. (2017). Cucurbitacin E reduces obesity and related metabolic dysfunction in mice by targeting JAK-STAT5 signaling pathway. Plos One: 1-13.
Paiva LB, Glodbeck R. Santos D, Squina FM. 2013. Ferulic acid and derivatives: molecules with potential application in the pharmaceutical field. Journal of pharmaceutical sciences 49 (3): 1-11.
Patel SB, Attar UA, Sakate DM, Ghane SG. (2020). Efficient extraction of cucurbitacin from Diplocyclos palmatus: optimization using response surface methodology, extraction methods and study of some important bioactivities. Scientific report 10: 2109.
Patel SB, Doble BW, McAulay K, Sinclair SM, Drucker DJ. (2008). Tissue specific role of GSK-3B in glucose homeostasis and insulin action. Molecular and cellular biology: 6314-6328.
Pimple, B., Kadam, P., Patil, M. (2011). Antidiabetic activity of Luffa acutangula fruit extracts in Streptozotocin induced NIDDM rats. Asian journal of Pharmaceutical and clinical research 4: 156-163.
Rachmania RA, Supandi, Christina FA. (2016). Analisis Penambatan Molekul Senyawa Flavonoid Buah Mahkota Dewa pada Reseptor α-Glukosidase Sebagai Antidiabetes. Pharmacy 13(2): 239-251.
Sharmin, R., Khan, M., Akhter M. (2013). Hypoglycemic and hypolipidemic effects of cucumber, whitepumpkin and ridge gourd in alloxan induced diabetic rats. Journal Sci. Res. 5: 161-171.
Sim L. Calvillo RQ, Sterchi EE, Nichols BL, Rose DR. (2008). Human Intestinal Maltase-Glucoamylase: Crystal Structure of the N-Terminal Catalytic Subunit and Basis of Inhibiton and Substrate Specificity. J. Mol Biol 375: 782-792.
Sivaprakasam P, Han X, Civiello RL, Porte SJ, Kish K. (2015). Discovery of new GSK-3 inhibitor by structure guided in-depth exploration of chemcial space around pyrrolopyridinone core. Bioorg. Med Chem. Lett.
Steuber H, Heine A, Klebe G. (2006). Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution. Journal of Molecular Biology 368(3): 618-638.
Suryanti V, Marliyana SD, Astuti Y. 2017. Chemical constituents of Luffa acutangula L. Fruit. International Conference on Food and Science 193 012050.
Takemura M, Endo S, Matsunaga T, Soda M, Zhao HT. (2017). Selective inhibiton of the tumor marker aldoketo reductase family member 1B10 by oleanolic acid. J. Nat. Prod. 74: 1201-1206.
Talele T, Khedkar SA, Rigby AC. (2010). Successful applications of computer aided drug design: moving drugs from concept to the clinic. Current topics in medicinal chemistry.10 (1): 127-141.
Xiang H, Han Y, Zhang Y, Yan W. 2017. A new oleanolic acid derivative against CCL4-induced hepatic fibrosis in rats. J Mol Sci. 1-15.
Zanger UM, Schwab M. 2013. Cytochrome P450 Enzymes in Drug Metabolism: Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation. Pharmacology & Therapeutics 138: 103–141.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
